Form 4: Bayview Legacy Sells 50,000 Arteris Shares

Bayview Legacy, LLC, a 10% owner and entity controlled by a director, reported the sale of 50,000 shares of Arteris, Inc. common stock under a 10b5-1 plan.

Summary

• Bayview Legacy, LLC, a 10% owner of Arteris, Inc. and an entity controlled by director K. Charles Janac, disposed of 50,000 shares of common stock.
• The transaction occurred on January 8, 2026, at a weighted average sale price of $16.5831 per share.
• The shares were sold in multiple transactions with prices ranging from $16.2150 to $17.3600.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Bayview Legacy, LLC on March 5, 2025.
• Following the transaction, Bayview Legacy, LLC indirectly beneficially owns 9,419,071 shares of Arteris, Inc. common stock.

Sentiment

Score: 4

Explanation: The sale by a significant owner and director-controlled entity, even under a 10b5-1 plan, can be viewed with slight caution by the market, though the pre-planned nature mitigates immediate negative implications. It's not overtly negative but also not a positive signal.

Positives

• The sale was conducted under a pre-arranged 10b5-1 trading plan, indicating a planned disposition rather than an immediate reaction to new, undisclosed information.

Negatives

• A significant sale of 50,000 shares by a 10% owner and director-controlled entity could be perceived negatively by the market, potentially signaling a lack of confidence or a need for liquidity.

Future Outlook

NA

Management Comments

• K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
• K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

Industry Context

This is an insider transaction specific to Arteris, Inc. and does not directly reflect broader industry trends, though investor sentiment towards semiconductor IP companies can influence stock performance.

Related Party Transactions

• The transaction involves Bayview Legacy, LLC, which is managed by K. Charles Janac, a director of Arteris, Inc. K. Charles Janac also filed a separate Form 4 for the same transaction, indicating a direct link between the reporting person and a key insider.

Stakeholder Impact

• Shareholders: May interpret the sale by a significant owner as a potential signal regarding future company performance or valuation, potentially leading to increased scrutiny or selling pressure.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request.

Key Dates

Recommendation

While a significant insider sale by a 10% owner and director-controlled entity could be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates immediate concerns of new adverse information. Investors should monitor future insider activity and company performance, but this single transaction, while notable, does not warrant an immediate 'sell' recommendation without further context. A 'hold' position is prudent to observe market reaction and subsequent developments.

Keywords

Arteris Inc., AIP, Bayview Legacy LLC, K. Charles Janac, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Beneficial Ownership, Semiconductor IP